Flow cytometric analysis of Hoechst 33342 uptake as an indicator of multi-drug resistance in human lung cancer
1989
Flow Cytometric Analysis of Drug Resistance in Lung Cancer
publication
Evidence: moderate
Author Information
Author(s): S.A. Morgan, J.V. Watson, P.R. Twentyman, P.J. Smith
Primary Institution: Clinical Oncology and Radiotherapeutics Unit, MRC, Addenbrooke's Hospital
Hypothesis
Can flow cytometry be used to monitor multi-drug resistance in lung cancer cell lines?
Conclusion
Different mechanisms of drug resistance may occur in lung tumors of different tissue types.
Supporting Evidence
- The study found a 30% reduction in nuclear binding of Hoechst 33342 in a drug-resistant SCLC cell line compared to its parental line.
- Verapamil treatment increased Hoechst 33342 binding in drug-resistant cells, indicating some ability to limit drug efflux.
- Different lung cancer cell lines showed varying responses to drug treatment, suggesting diverse resistance mechanisms.
Takeaway
This study looks at how lung cancer cells resist drugs and uses a special dye to see how well the drugs get into the cells.
Methodology
Flow cytometry was used to analyze Hoechst 33342 dye uptake in drug-resistant and non-resistant lung cancer cell lines.
Limitations
The study does not identify specific mechanisms affecting drug uptake in different cell lines.
Want to read the original?
Access the complete publication on the publisher's website